5,965 Shares in Elevance Health, Inc. (NYSE:ELV) Purchased by Second Half Financial Partners LLC

Second Half Financial Partners LLC acquired a new stake in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 5,965 shares of the company's stock, valued at approximately $2,813,000. Elevance Health makes up 1.4% of Second Half Financial Partners LLC's investment portfolio, making the stock its 23rd biggest position.

Other institutional investors also recently added to or reduced their stakes in the company. Alliance Wealth Advisors LLC boosted its holdings in shares of Elevance Health by 2.9% in the fourth quarter. Alliance Wealth Advisors LLC now owns 745 shares of the company's stock valued at $351,000 after buying an additional 21 shares during the period. Clearstead Advisors LLC boosted its stake in Elevance Health by 0.9% in the 3rd quarter. Clearstead Advisors LLC now owns 2,516 shares of the company's stock worth $1,096,000 after purchasing an additional 22 shares during the period. Financial Counselors Inc. increased its holdings in Elevance Health by 1.0% during the 3rd quarter. Financial Counselors Inc. now owns 2,284 shares of the company's stock worth $994,000 after purchasing an additional 22 shares in the last quarter. Capital Investment Advisors LLC increased its holdings in Elevance Health by 2.5% during the 4th quarter. Capital Investment Advisors LLC now owns 887 shares of the company's stock worth $418,000 after purchasing an additional 22 shares in the last quarter. Finally, Sugarloaf Wealth Management LLC raised its stake in shares of Elevance Health by 8.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 277 shares of the company's stock valued at $131,000 after purchasing an additional 22 shares during the period. 89.24% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Elevance Health

In related news, EVP Felicia F. Norwood sold 14,111 shares of the business's stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $533.74, for a total value of $7,531,605.14. Following the completion of the sale, the executive vice president now directly owns 31,460 shares in the company, valued at $16,791,460.40. The sale was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.29% of the company's stock.

Elevance Health Stock Performance

Elevance Health stock traded up $5.36 during midday trading on Wednesday, reaching $539.99. 686,421 shares of the company's stock were exchanged, compared to its average volume of 1,027,434. Elevance Health, Inc. has a 52 week low of $412.00 and a 52 week high of $543.13. The firm has a market cap of $125.50 billion, a price-to-earnings ratio of 20.41, a P/E/G ratio of 1.19 and a beta of 0.79. The stock's 50-day simple moving average is $518.12 and its 200 day simple moving average is $493.35. The company has a debt-to-equity ratio of 0.54, a quick ratio of 1.37 and a current ratio of 1.37.

Elevance Health (NYSE:ELV - Get Free Report) last posted its earnings results on Thursday, April 18th. The company reported $10.64 earnings per share for the quarter, topping analysts' consensus estimates of $10.54 by $0.10. Elevance Health had a return on equity of 20.62% and a net margin of 3.64%. The company had revenue of $42.27 billion during the quarter, compared to the consensus estimate of $42.49 billion. During the same quarter last year, the firm earned $9.46 earnings per share. The company's revenue was up .9% on a year-over-year basis. On average, analysts expect that Elevance Health, Inc. will post 37.26 earnings per share for the current fiscal year.

Elevance Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Monday, June 10th will be given a dividend of $1.63 per share. The ex-dividend date is Monday, June 10th. This represents a $6.52 dividend on an annualized basis and a dividend yield of 1.21%. Elevance Health's payout ratio is presently 24.64%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on ELV. Mizuho increased their price objective on Elevance Health from $575.00 to $585.00 and gave the stock a "buy" rating in a report on Wednesday, April 24th. StockNews.com cut shares of Elevance Health from a "strong-buy" rating to a "buy" rating in a research note on Thursday, January 25th. Royal Bank of Canada boosted their price objective on shares of Elevance Health from $574.00 to $575.00 and gave the stock an "outperform" rating in a research report on Friday, April 19th. Jefferies Financial Group increased their target price on shares of Elevance Health from $602.00 to $604.00 and gave the stock a "buy" rating in a report on Friday, April 19th. Finally, UBS Group lifted their price target on shares of Elevance Health from $585.00 to $605.00 and gave the company a "buy" rating in a research note on Friday, April 19th. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, Elevance Health presently has a consensus rating of "Moderate Buy" and an average price target of $587.42.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.

Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.